Klus Pharma

Klus Pharma is a company developing biologics for the treatment of cancer and cardiovascular diseases. It provides its proprietary antibody discovery platform, including hybridoma technology and phage display, that allows creating monoclonal antibodies, multi-specific antibodies, and antibody-drug conjugates from bench to market.